Poster Presentation: Phase 2a Trial of AB-101a for Mild-to-Moderate Atopic Dermatitis, Pediatric Patients
Poster Presentation: Phase 2a Trial of AB-101a for Mild-to-Moderate Atopic Dermatitis, Pediatric Patients NEWS PROVIDED BY Alphyn Biologics May 4, 2023, 07:25 ET CONTACTS Corporate: Neal Koller nkoller@alphynbiologics.com (410) 690-8687 Media: Susan Thomas susan@endpointcommunications.net (619) 540-9195